{"database": "press", "table": "releases", "rows": [["https://buddycarter.house.gov/news/documentsingle.aspx?DocumentID=16584", "WATCH: CARTER SPEAKS OUT AGAINST UNNECESSARY ANIMAL TESTING", "2026-07-20", "2026", "2026-07", "Republican", "House", "GA", "Earl L. \"Buddy\" Carter", "C001103", "buddycarter.house.gov", "buddycarter", "https://buddycarter.house.gov/news/documentquery.aspx?DocumentTypeID=27", "scraper", "WASHINGTON, D.C. \u2013 Rep. Earl L. \u201cBuddy\u201d Carter (R-GA) today spoke on the House Floor in support of his bill, the FDA Modernization Act 3.0. This bipartisan legislation would bring the Food and Drug Administration\u2019s (FDA) regulations into the 21st century by recognizing modern, safe, and effective alternatives to traditional animal testing when possible.\n\nThe bill requires the FDA to update outdated regulations to reflect current law, providing researchers with greater flexibility to use innovative nonclinical testing methods without compromising the agency's gold standard for drug safety and effectiveness.\n\nWatch Rep. Carter\u2019s floor remarks here:\n\n\u201cMr. Speaker, I rise today in strong support of my bill, H.R. 2821, the FDA Modernization Act 3.0, bipartisan legislation that ensures the FDA fully embraces modern science while reducing unnecessary animal testing.\n\nMany of our families would feel incomplete without the pets and animals that bring unconditional love into our lives.\n\nYet every year, millions of animals, including dogs, man's best friend, are still subjected to testing in the development of new medicines.\n\nAs policymakers, we have a responsibility to protect those who cannot protect themselves.\n\nThat responsibility includes embracing scientific innovation that can reduce unnecessary animal suffering while continuing to deliver safe and effective treatments to patients.\n\nIn 2022, Congress took an important first step by passing the FDA Modernization Act 2.0.\n\nI was proud to help lead that effort.\n\nThat law gave drug developers the ability to use modern, scientifically validated alternatives to traditional animal testing when appropriate.\n\nCongress made its intent clear.\n\nWe wanted to encourage more effective, more humane, and more innovative approaches to drug development.\n\nUnfortunately, the previous administration failed to fully implement the law.\n\nWithout clear implementation, too many researchers have lacked the certainty they need, and too many animals continue to be used in testing that modern science can increasingly replace.\n\nH.R. 2821 ensures the FDA finally carries out the will of Congress.\n\nThis bill is not about lowering standards. It is about raising them.\n\nToday's researchers have access to technologies that simply did not exist a generation ago.\n\nAdvanced human cell models. Organ-on-a-chip technology. Artificial intelligence and computational modeling.\n\nThese innovative tools have the potential to better predict how medicines will perform in humans while reducing reliance on animal testing.\n\nOur laws should reflect the science of today, not the science of decades past.\n\nModernizing drug development doesn't just benefit animals. It benefits patients.\n\nBy providing greater clarity and encouraging the use of validated alternative methods, we can help make the drug development process more efficient.\n\nThat means fewer unnecessary delays and more innovation.\n\nAnd ultimately, that means lifesaving treatments can reach patients more quickly without compromising the FDA's rigorous standards for safety and effectiveness.\n\nThis is a commonsense, bipartisan bill. It reflects a simple principle.\n\nWe can advance medical innovation while improving animal welfare.\n\nThose goals are not in conflict. In fact, they go hand in hand.\n\nMr. Speaker, the FDA Modernization Act 3.0 fulfills the promise Congress made when we passed FDA Modernization Act 2.0.\n\nIt ensures that modern science is fully incorporated into our regulatory process.\n\nIt helps reduce unnecessary animal testing and strengthens American medical innovation.\n\nAnd it helps bring new therapies to patients more efficiently.\n\nI urge my colleagues to support H.R. 2821, the FDA Modernization Act 3.0.\u201d", 1, "2026-07-21T07:32:02Z", "2026-07-21T07:33:33Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://buddycarter.house.gov/news/documentsingle.aspx?DocumentID=16584"], "units": {}, "query_ms": 1.4349590055644512, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}